Conserved Oncogenic Behavior of the FAM83 Family Regulates MAPK Signaling in Human Cancer
Open Access
- 14 August 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 12 (8), 1156-1165
- https://doi.org/10.1158/1541-7786.mcr-13-0289
Abstract
FAM83B (family with sequence similarity 83, member B) was recently identified as a novel oncogene involved in activating CRAF/MAPK signaling and driving epithelial cell transformation. FAM83B is one of eight members of a protein family (FAM83) characterized by a highly conserved domain of unknown function (DUF1669), which is necessary and sufficient to drive transformation. Here, it is demonstrated that additional FAM83 members also exhibit oncogenic properties and have significantly elevated levels of expression in multiple human tumor types using a TissueScan Cancer Survey Panel PCR array and database mining. Furthermore, modeling the observed tumor expression of FAM83A, FAM83C, FAM83D, or FAM83E promoted human mammary epithelial cell (HMEC) transformation, which correlated with the ability of each FAM83 member to bind CRAF (RAF1) and promote CRAF membrane localization. Conversely, ablation of FAM83A or FAM83D from breast cancer cells resulted in diminished MAPK signaling with marked suppression of growth in vitro and tumorigenicity in vivo. Importantly, each FAM83 member was determined to be elevated in at least one of 17 distinct tumor types examined, with FAM83A, FAM83B, and FAM83D most frequently overexpressed in several diverse tissue types. Finally, evidence suggests that elevated expression of FAM83 members is associated with elevated tumor grade and decreased overall survival. Implications: FAM83 proteins represent a novel family of oncogenes suitable for the development of cancer therapies aimed at suppressing MAPK signaling. Mol Cancer Res; 12(8); 1156–65. ©2014 AACR.Keywords
Other Versions
This publication has 18 references indexed in Scilit:
- Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83BOncogene, 2013
- FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapiesOncotarget, 2013
- FAM83B mediates EGFR- and RAS-driven oncogenic transformationJCI Insight, 2012
- FAM83A confers EGFR-TKI resistance in breast cancer cells and in miceJCI Insight, 2012
- Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistanceNature Medicine, 2012
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast CancerCell, 2012
- Growth factor signaling pathways as targets for prevention of epithelial carcinogenesisMolecular Carcinogenesis, 2011
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- The Spindle Protein CHICA Mediates Localization of the Chromokinesin Kid to the Mitotic SpindleCurrent Biology, 2008
- p53-Mediated Growth Suppression in Response to Nutlin-3 in Cyclin D1–Transformed Cells Occurs Independently of p21Cancer Research, 2007